Theragen Etex Co.Ltd (066700) — Capital Reinvestment Ratio
Theragen Etex Co.Ltd (066700) has a Capital Reinvestment Ratio of 0.36x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩3.79 Billion) in capital expenditures (₩1.35 Billion). See Theragen Etex Co.Ltd balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Theragen Etex Co.Ltd Capital Reinvestment Ratio (2008–2025)
This chart tracks Theragen Etex Co.Ltd's Capital Reinvestment Ratio across 10 annual periods. Check 066700 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Theragen Etex Co.Ltd (2008–2025)
Year-by-year Capital Reinvestment Ratio for Theragen Etex Co.Ltd from 2008 to 2025. For live market cap and broader valuation context, see market value of Theragen Etex Co.Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.47x | ₩10.97 Billion | ₩5.20 Billion | ▼ -92.6% |
| 2024 | 6.37x | ₩1.79 Billion | ₩11.39 Billion | ▲ +1510.4% |
| 2023 | 0.40x | ₩12.12 Billion | ₩4.80 Billion | ▼ -9.5% |
| 2022 | 0.44x | ₩9.59 Billion | ₩4.19 Billion | ▼ -36.3% |
| 2021 | 0.69x | ₩4.01 Billion | ₩2.75 Billion | ▲ +201.3% |
| 2020 | 0.23x | ₩13.23 Billion | ₩3.01 Billion | ▼ -99.8% |
| 2019 | 123.01x | ₩37.69 Million | ₩4.64 Billion | ▲ +7384.3% |
| 2017 | 1.64x | ₩1.78 Billion | ₩2.92 Billion | ▼ -96.4% |
| 2014 | 45.34x | ₩39.95 Million | ₩1.81 Billion | ▲ +37789.2% |
| 2008 | 0.12x | ₩3.14 Billion | ₩376.03 Million | — |